177 related articles for article (PubMed ID: 7954255)
1. Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse.
Sinicrope FA; Hart J; Brasitus TA; Michelassi F; Lee JJ; Safa AR
Cancer; 1994 Dec; 74(11):2908-17. PubMed ID: 7954255
[TBL] [Abstract][Full Text] [Related]
2. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry.
Albe X; Vassilakos P; Helfer-Guarnori K; Givel JC; de Quay N; Suardet L; Eliason JF; Odartchenko N
Cancer; 1990 Sep; 66(6):1168-75. PubMed ID: 2400968
[TBL] [Abstract][Full Text] [Related]
3. Relationships among tenascin expression, DNA ploidy patterns, and multidrug resistance gene product (P-glycoprotein) in human colon carcinoma.
Sugawara I; Hirakoshi J; Kusakabe M; Masunaga A; Itoyama S; Sakakura T
Jpn J Cancer Res; 1993 Jul; 84(7):703-7. PubMed ID: 7690353
[TBL] [Abstract][Full Text] [Related]
4. Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells.
Ding Z; Yang L; Xie X; Xie F; Pan F; Li J; He J; Liang H
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1697-707. PubMed ID: 20217131
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of multidrug-resistance-associated antigen (P-glycoprotein) and DNA ploidy in human colon cancer.
Danova M; Giordano M; Erba E; Palmeri S; Candiloro V; Riccardi A; Ucci G; Mazzini G; D'Incalci M; Ascari E
J Cancer Res Clin Oncol; 1992; 118(8):575-80. PubMed ID: 1355483
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern.
Scott NA; Wieand HS; Moertel CG; Cha SS; Beart RW; Lieber MM
Arch Surg; 1987 Dec; 122(12):1375-9. PubMed ID: 3689111
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients.
Sinicrope FA; Rego RL; Halling KC; Foster N; Sargent DJ; La Plant B; French AJ; Laurie JA; Goldberg RM; Thibodeau SN; Witzig TE
Gastroenterology; 2006 Sep; 131(3):729-37. PubMed ID: 16952542
[TBL] [Abstract][Full Text] [Related]
9. Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen.
Liu C; Dong B; Lu A; Qu L; Xing X; Meng L; Wu J; Eric Shi Y; Shou C
BMC Cancer; 2010 Jul; 10():359. PubMed ID: 20604972
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma.
Sinicrope FA; Hart J; Michelassi F; Lee JJ
Clin Cancer Res; 1995 Oct; 1(10):1103-10. PubMed ID: 9815900
[TBL] [Abstract][Full Text] [Related]
11. Ploidy as a prognostic feature in colonic adenocarcinoma.
Takanishi DM; Hart J; Covarelli P; Chappell R; Michelassi F
Arch Surg; 1996 Jun; 131(6):587-92. PubMed ID: 8645063
[TBL] [Abstract][Full Text] [Related]
12. P-Gp and TOPO II Expression and Their Clinical Significance in Colon Cancer.
Dang Y; Liu F; Zhao Y
Ann Clin Lab Sci; 2020 Sep; 50(5):584-590. PubMed ID: 33067204
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
Sinicrope FA; Hart J; Hsu HA; Lemoine M; Michelassi F; Stephens LC
Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084
[TBL] [Abstract][Full Text] [Related]
15. Tumor ploidy as a risk factor for disease recurrence and short survival in surgically treated Dukes' B2 colon cancer patients.
Nori D; Merimsky O; Saw D; Cortes E; Chen E; Chassin J
Tumour Biol; 1996; 17(2):75-80. PubMed ID: 8658016
[TBL] [Abstract][Full Text] [Related]
16. Tumor ploidy as a risk factor for disease recurrence and short survival in surgically-treated Dukes' B2 colon cancer patients.
Nori D; Merimsky O; Samala E; Saw D; Cortes E; Chen E; Turner JW
J Surg Oncol; 1995 Aug; 59(4):239-42. PubMed ID: 7630171
[TBL] [Abstract][Full Text] [Related]
17. Serum carcinoembryonic antigen in relation to survival, DNA ploidy pattern, and recurrent disease in 406 colorectal carcinoma patients.
Meling GI; Rognum TO; Clausen OP; Børmer O; Lunde OC; Schlichting E; Grüner OP; Hognestad J; Trondsen E; Havig O
Scand J Gastroenterol; 1992 Dec; 27(12):1061-8. PubMed ID: 1475624
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
19. Serum carcinoembryonic antigen and DNA ploidy in colorectal carcinoma. A prospective study.
Kouri M; Pyrhönen S; Mecklin JP; Järvinen H; Laasonen A; Franssila K; Kuusela P; Nordling S
Scand J Gastroenterol; 1991 Aug; 26(8):812-8. PubMed ID: 1771385
[TBL] [Abstract][Full Text] [Related]
20. Expression of the multidrug-resistance gene product in untreated human breast cancer and its relationship to prognostic markers.
De La Torre M; Larsson R; Nygren P; Lindgren A; Bergh J
Acta Oncol; 1994; 33(7):773-7. PubMed ID: 7993645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
